Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities.
作者信息
Stogios Nicolette, Hahn Margaret K, Lunsky Yona, Desarkar Pushpal, Agarwal Sri Mahavir
机构信息
From the Institute of Medical Science, University of Toronto, Toronto, Ont. (Stogios, Hahn, Desarkar, Agarwal); the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Hahn, Lunsky, Desarkar, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal); the Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Lunsky, Desarkar).
出版信息
J Psychiatry Neurosci. 2023 Mar 14;48(2):E99-E101. doi: 10.1503/jpn.220200. Print 2023 Mar-Apr.
Abstract
摘要
相似文献
1
Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities.二甲双胍用于治疗智力和发育障碍患者的抗精神病药物所致代谢紊乱。
J Psychiatry Neurosci. 2023 Mar 14;48(2):E99-E101. doi: 10.1503/jpn.220200. Print 2023 Mar-Apr.
2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.解决使用抗精神病药物的智力和发育障碍个体的代谢合并症：临床病例系列
J Clin Psychopharmacol. 2023;43(1):60-63. doi: 10.1097/JCP.0000000000001626. Epub 2022 Nov 17.
3
Re: Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.关于：非典型抗精神病药物在治疗发育障碍青少年和青年中的应用。
Can J Psychiatry. 2002 Oct;47(8):785; author reply 785-6. doi: 10.1177/070674370204700817.
4
Movement disorders in children with developmental disabilities taking risperidone.服用利培酮的发育障碍儿童的运动障碍
J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):5-6. doi: 10.1097/00004583-199901000-00009.
5
Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study.安非他命在安大略省有智力和发育障碍的成年人中的起始使用：一项基于人群的队列研究。
BMJ Open. 2019 Jul 30;9(7):e028125. doi: 10.1136/bmjopen-2018-028125.
6
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.二甲双胍治疗自闭症谱系障碍青少年使用非典型抗精神病药物引起的超重：一项随机临床试验。
JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.
7
The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.阿立哌唑治疗智力残疾、发育障碍和/或自闭症谱系障碍患者问题行为的有效性——一项系统评价
Res Dev Disabil. 2014 Mar;35(3):711-25. doi: 10.1016/j.ridd.2013.12.004. Epub 2014 Jan 7.
8
Metformin for Antipsychotic-Related Metabolic Syndrome in Children: Fact or Fiction?二甲双胍用于治疗儿童抗精神病药物相关代谢综合征：事实还是虚构？
Chin Med J (Engl). 2018 Jun 20;131(12):1490-1491. doi: 10.4103/0366-6999.233944.
9
Neurobehavioral assessment of children and adolescents attending a developmental disabilities clinic.对一家发育障碍诊所的儿童和青少年进行神经行为评估。
Psychol Rep. 2004 Dec;95(3 Pt 2):1079-86. doi: 10.2466/pr0.95.3f.1079-1086.
10
A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.一项针对使用抗精神病药物治疗自闭症谱系障碍的年轻人超重的二甲双胍治疗的随机、安慰剂对照试验：开放标签扩展。
J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):849-856.e6. doi: 10.1016/j.jaac.2017.07.790. Epub 2017 Aug 19.
引用本文的文献
1
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies.药物性高血糖与糖尿病：当前文献综述及实际管理策略
Diabetes Ther. 2024 Sep;15(9):2001-2025. doi: 10.1007/s13300-024-01628-0. Epub 2024 Jul 31.
2
Potential biomarkers and therapeutic targets for obsessive compulsive disorder: Evidences from clinical studies.强迫症的潜在生物标志物和治疗靶点：来自临床研究的证据。
Biochem Med (Zagreb). 2024 Feb 15;34(1):010503. doi: 10.11613/BM.2024.010503. Epub 2023 Dec 15.
本文引用的文献
1
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.解决使用抗精神病药物的智力和发育障碍个体的代谢合并症：临床病例系列
J Clin Psychopharmacol. 2023;43(1):60-63. doi: 10.1097/JCP.0000000000001626. Epub 2022 Nov 17.
2
Pharmacological interventions for prevention of weight gain in people with schizophrenia.预防精神分裂症患者体重增加的药物干预。
Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2.
3
The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta-analysis.智力和/或发育障碍个体使用抗精神病药物的代谢不良反应：一项系统评价和荟萃分析。
Acta Psychiatr Scand. 2022 Sep;146(3):201-214. doi: 10.1111/acps.13484. Epub 2022 Aug 5.
4
Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis.第二代抗精神病药物在成年人群中标签外使用的代谢不良影响：系统评价和荟萃分析。
Neuropsychopharmacology. 2022 Feb;47(3):664-672. doi: 10.1038/s41386-021-01163-7. Epub 2021 Aug 26.
5
Metabolic syndrome and its components in people with intellectual disability: a meta-analysis.智力残疾人群中的代谢综合征及其组成部分：一项荟萃分析。
J Intellect Disabil Res. 2020 Oct;64(10):804-815. doi: 10.1111/jir.12772. Epub 2020 Sep 7.
6
Obesity in adults: a clinical practice guideline.成人肥胖：临床实践指南。
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
7
Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis.二甲双胍对抗精神病药物所致代谢功能障碍的影响：肠-脑轴的潜在作用
Front Pharmacol. 2019 Apr 9;10:371. doi: 10.3389/fphar.2019.00371. eCollection 2019.
8
Metformin in 2019.二甲双胍 2019 年资料
JAMA. 2019 May 21;321(19):1926-1927. doi: 10.1001/jama.2019.3805.
9
Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.与精神病和抗精神病药物治疗相关的代谢紊乱的潜在机制。
J Psychopharmacol. 2017 Nov;31(11):1430-1436. doi: 10.1177/0269881117722987. Epub 2017 Sep 11.
10
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.二甲双胍治疗自闭症谱系障碍青少年使用非典型抗精神病药物引起的超重：一项随机临床试验。
JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.
Zotero 插件